Revenue: The sum of all revenue fields included for a company's operating activities.
Recursion Pharmaceuticals, Inc. (RXRX) had Revenue of $10.89M for the most recently reported fiscal quarter, ending 2023-12-31.
| Income Statement Financials | |
|
Revenue |
$10.89M |
$-93.00M |
|
$9.88M |
|
$1.01M |
|
$109.82M |
|
$-98.93M |
|
$1.87M |
|
$-97.06M |
|
$-97.06M |
|
$-93.00M |
|
$-93.00M |
|
$-93.00M |
|
$-93.00M |
|
$-98.93M |
|
$-91.38M |
|
207.85M |
|
207.85M |
|
$-0.43 |
|
$-0.43 |
|
| Balance Sheet Financials | |
$438.14M |
|
$86.51M |
|
$215.56M |
|
$653.70M |
|
$93.17M |
|
$1.10M |
|
$97.09M |
|
$190.26M |
|
$463.44M |
|
$374.94M |
|
$463.44M |
|
234.27M |
|
| Cash Flow Statement Financials | |
$-287.78M |
|
$-10.23M |
|
$140.13M |
|
$559.11M |
|
$401.43M |
|
$-157.69M |
|
$53.50M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
4.70 |
|
-- |
|
-- |
|
0.00 |
|
0.00 |
|
9.28% |
|
-908.36% |
|
-908.36% |
|
-- |
|
-891.18% |
|
-853.88% |
|
$-299.74M |
|
-- |
|
-- |
|
-- |
|
0.02 |
|
-- |
|
3.52 |
|
25.57 |
|
-20.07% |
|
-24.80% |
|
-14.23% |
|
-20.02% |
|
$1.98 |
|
$-1.44 |
|
$-1.38 |
|